nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—nerve—Parkinson's disease	0.0568	0.167	CbGeAlD
Amcinonide—ANXA1—embryo—Parkinson's disease	0.0266	0.0783	CbGeAlD
Amcinonide—ANXA1—Spinal Cord Injury—AIF1—Parkinson's disease	0.0263	0.0402	CbGpPWpGaD
Amcinonide—ANXA1—forebrain—Parkinson's disease	0.0235	0.0693	CbGeAlD
Amcinonide—ANXA1—cardiovascular system—Parkinson's disease	0.0199	0.0586	CbGeAlD
Amcinonide—NR3C1—nerve—Parkinson's disease	0.0197	0.0581	CbGeAlD
Amcinonide—ANXA1—medulla oblongata—Parkinson's disease	0.017	0.0501	CbGeAlD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—EDN1—Parkinson's disease	0.0163	0.0249	CbGpPWpGaD
Amcinonide—ANXA1—midbrain—Parkinson's disease	0.0155	0.0457	CbGeAlD
Amcinonide—ANXA1—spinal cord—Parkinson's disease	0.0152	0.0446	CbGeAlD
Amcinonide—NR3C1—hindbrain—Parkinson's disease	0.0148	0.0435	CbGeAlD
Amcinonide—ANXA1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.0138	0.0211	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—GPR37—Parkinson's disease	0.0136	0.0208	CbGpPWpGaD
Amcinonide—ANXA1—head—Parkinson's disease	0.0135	0.0397	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptors—NR4A2—Parkinson's disease	0.0133	0.0203	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—GDNF—Parkinson's disease	0.0128	0.0196	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MAG—Parkinson's disease	0.0128	0.0196	CbGpPWpGaD
Amcinonide—ANXA1—nervous system—Parkinson's disease	0.0128	0.0376	CbGeAlD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.0123	0.0188	CbGpPWpGaD
Amcinonide—ANXA1—central nervous system—Parkinson's disease	0.0123	0.0362	CbGeAlD
Amcinonide—ANXA1—Spinal Cord Injury—VIM—Parkinson's disease	0.0121	0.0184	CbGpPWpGaD
Amcinonide—ANXA1—cerebellum—Parkinson's disease	0.012	0.0354	CbGeAlD
Amcinonide—ANXA1—Spinal Cord Injury—PDYN—Parkinson's disease	0.0117	0.0179	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—GFAP—Parkinson's disease	0.011	0.0169	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—PLA2G6—Parkinson's disease	0.0106	0.0162	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0105	0.016	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.0105	0.016	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—INSR—Parkinson's disease	0.0104	0.0159	CbGpPWpGaD
Amcinonide—ANXA1—brain—Parkinson's disease	0.00976	0.0287	CbGeAlD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.00935	0.0143	CbGpPWpGaD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—Parkinson's disease	0.00928	0.0142	CbGpPWpGaD
Amcinonide—NR3C1—embryo—Parkinson's disease	0.00924	0.0272	CbGeAlD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00913	0.0139	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—PENK—Parkinson's disease	0.00877	0.0134	CbGpPWpGaD
Amcinonide—NR3C1—brainstem—Parkinson's disease	0.00847	0.0249	CbGeAlD
Amcinonide—NR3C1—forebrain—Parkinson's disease	0.00817	0.0241	CbGeAlD
Amcinonide—ANXA1—Peptide ligand-binding receptors—PDYN—Parkinson's disease	0.00802	0.0123	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—GRM4—Parkinson's disease	0.00781	0.0119	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00779	0.0119	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.00756	0.0115	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—PENK—Parkinson's disease	0.0074	0.0113	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GPR37—Parkinson's disease	0.00695	0.0106	CbGpPWpGaD
Amcinonide—NR3C1—cardiovascular system—Parkinson's disease	0.00691	0.0203	CbGeAlD
Amcinonide—ANXA1—G alpha (i) signalling events—PDYN—Parkinson's disease	0.00677	0.0103	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00676	0.0103	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00665	0.0102	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00646	0.00987	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PENK—Parkinson's disease	0.00616	0.00941	CbGpPWpGaD
Amcinonide—NR3C1—medulla oblongata—Parkinson's disease	0.0059	0.0174	CbGeAlD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00589	0.00899	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—BDNF—Parkinson's disease	0.00565	0.00863	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—ADRBK1—Parkinson's disease	0.00551	0.00841	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00549	0.00839	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—TAC1—Parkinson's disease	0.00542	0.00828	CbGpPWpGaD
Amcinonide—NR3C1—midbrain—Parkinson's disease	0.0054	0.0159	CbGeAlD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00538	0.00822	CbGpPWpGaD
Amcinonide—NR3C1—spinal cord—Parkinson's disease	0.00526	0.0155	CbGeAlD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00504	0.0077	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00491	0.0075	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00487	0.00744	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GRM4—Parkinson's disease	0.00473	0.00722	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.00471	0.00719	CbGpPWpGaD
Amcinonide—NR3C1—head—Parkinson's disease	0.00468	0.0138	CbGeAlD
Amcinonide—ANXA1—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.00464	0.00709	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—PENK—Parkinson's disease	0.00448	0.00685	CbGpPWpGaD
Amcinonide—NR3C1—nervous system—Parkinson's disease	0.00444	0.0131	CbGeAlD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00435	0.00665	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—DRD3—Parkinson's disease	0.00434	0.00663	CbGpPWpGaD
Amcinonide—NR3C1—central nervous system—Parkinson's disease	0.00427	0.0126	CbGeAlD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00425	0.0065	CbGpPWpGaD
Amcinonide—NR3C1—cerebellum—Parkinson's disease	0.00417	0.0123	CbGeAlD
Amcinonide—ANXA1—GPCR ligand binding—PDYN—Parkinson's disease	0.0041	0.00626	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00393	0.006	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00393	0.006	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.0039	0.00596	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00384	0.00587	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GRM5—Parkinson's disease	0.00381	0.00582	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00378	0.00577	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00378	0.00577	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—EDN1—Parkinson's disease	0.00373	0.00569	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00369	0.00564	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00364	0.00555	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00357	0.00545	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GPR37—Parkinson's disease	0.00357	0.00545	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00357	0.00545	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00345	0.00527	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00341	0.00521	CbGpPWpGaD
Amcinonide—NR3C1—brain—Parkinson's disease	0.00339	0.00998	CbGeAlD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00338	0.00516	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TH—Parkinson's disease	0.00333	0.00508	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.0033	0.00504	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.00328	0.005	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00326	0.00499	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00324	0.00495	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00314	0.0048	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Parkinson's disease	0.00314	0.0048	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00312	0.00477	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00312	0.00477	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00298	0.00455	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00295	0.00451	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL1B—Parkinson's disease	0.00283	0.00432	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CASP3—Parkinson's disease	0.00282	0.00431	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00281	0.00429	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—TAC1—Parkinson's disease	0.00277	0.00423	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—DRD1—Parkinson's disease	0.00272	0.00415	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRK5—Parkinson's disease	0.0027	0.00413	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00267	0.00408	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Parkinson's disease	0.00264	0.00403	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—DRD3—Parkinson's disease	0.00263	0.00402	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—EDN1—Parkinson's disease	0.00262	0.004	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VPS35—Parkinson's disease	0.00254	0.00389	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PENK—Parkinson's disease	0.00253	0.00387	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.0025	0.00382	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—Parkinson's disease	0.00249	0.0038	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRM4—Parkinson's disease	0.00243	0.00371	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR7—Parkinson's disease	0.00238	0.00363	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—DRD2—Parkinson's disease	0.00238	0.00363	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.00232	0.00354	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00232	0.00354	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PENK—Parkinson's disease	0.0023	0.00351	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00219	0.00334	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00215	0.00329	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00212	0.00323	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DGKQ—Parkinson's disease	0.00211	0.00322	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GPR37—Parkinson's disease	0.00211	0.00322	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PDYN—Parkinson's disease	0.0021	0.00321	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—Parkinson's disease	0.00205	0.00314	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00204	0.00311	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—Parkinson's disease	0.00201	0.00307	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00201	0.00306	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRM5—Parkinson's disease	0.00196	0.00299	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00193	0.00295	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.00192	0.00293	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—EDN1—Parkinson's disease	0.0019	0.00291	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00183	0.0028	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00181	0.00276	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.00176	0.0027	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00175	0.00268	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RIT2—Parkinson's disease	0.00169	0.00257	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00167	0.00254	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00166	0.00254	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—Parkinson's disease	0.00166	0.00253	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRK5—Parkinson's disease	0.0016	0.00244	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00159	0.00243	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00156	0.00239	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.00156	0.00238	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00153	0.00234	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00149	0.00227	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00148	0.00226	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00144	0.0022	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM4—Parkinson's disease	0.00143	0.00219	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00143	0.00218	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—TAC1—Parkinson's disease	0.00142	0.00217	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.0014	0.00213	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—DRD1—Parkinson's disease	0.00139	0.00213	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00139	0.00212	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAG—Parkinson's disease	0.00136	0.00208	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PENK—Parkinson's disease	0.00136	0.00208	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—DRD3—Parkinson's disease	0.00135	0.00206	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—DRD2—Parkinson's disease	0.00134	0.00205	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR7—Parkinson's disease	0.00134	0.00205	CbGpPWpGaD
Amcinonide—Ciclesonide—CYP2D6—Parkinson's disease	0.00127	0.221	CrCbGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00127	0.00194	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00126	0.00192	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDYN—Parkinson's disease	0.00124	0.0019	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PRKRA—Parkinson's disease	0.00124	0.00189	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR7—Parkinson's disease	0.00122	0.00186	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—DRD2—Parkinson's disease	0.00122	0.00186	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00121	0.00184	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GFAP—Parkinson's disease	0.00117	0.00178	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM5—Parkinson's disease	0.00116	0.00176	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—INS—Parkinson's disease	0.00111	0.00169	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Parkinson's disease	0.0011	0.00168	CbGpPWpGaD
Amcinonide—Fluticasone furoate—ABCB1—Parkinson's disease	0.00109	0.19	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—EDN1—Parkinson's disease	0.00108	0.00164	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.00103	0.00157	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGF20—Parkinson's disease	0.00101	0.00155	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000982	0.0015	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EDN1—Parkinson's disease	0.000977	0.00149	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000941	0.00144	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—INSR—Parkinson's disease	0.000906	0.00138	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TAF1—Parkinson's disease	0.000871	0.00133	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NR4A2—Parkinson's disease	0.000871	0.00133	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGB—Parkinson's disease	0.000857	0.00131	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000855	0.00131	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR1A—Parkinson's disease	0.000852	0.0013	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TAC1—Parkinson's disease	0.000839	0.00128	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DRD1—Parkinson's disease	0.000823	0.00126	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—CTGF—Parkinson's disease	0.000816	0.00125	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DRD3—Parkinson's disease	0.000797	0.00122	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—Parkinson's disease	0.000795	0.00121	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000744	0.00114	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DRD2—Parkinson's disease	0.000721	0.0011	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR7—Parkinson's disease	0.000721	0.0011	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000715	0.00109	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000713	0.00109	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—Parkinson's disease	0.0007	0.00107	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPL6—Parkinson's disease	0.000697	0.00106	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2E1—Parkinson's disease	0.000666	0.116	CrCbGaD
Amcinonide—Prednisone—ABCB1—Parkinson's disease	0.000665	0.116	CrCbGaD
Amcinonide—Prednisolone—ABCB1—Parkinson's disease	0.000613	0.107	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—IGF2—Parkinson's disease	0.000604	0.000923	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—Parkinson's disease	0.0006	0.000917	CbGpPWpGaD
Amcinonide—Betamethasone—ABCB1—Parkinson's disease	0.0006	0.105	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1R—Parkinson's disease	0.000584	0.000892	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EDN1—Parkinson's disease	0.000577	0.000882	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NGF—Parkinson's disease	0.00053	0.00081	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPL23A—Parkinson's disease	0.000528	0.000806	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPL14—Parkinson's disease	0.000528	0.000806	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000519	0.000793	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2A—Parkinson's disease	0.000505	0.000771	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPS8—Parkinson's disease	0.000492	0.000752	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2D6—Parkinson's disease	0.000489	0.0852	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—IL6—Parkinson's disease	0.000484	0.00074	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—Parkinson's disease	0.000469	0.000717	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000419	0.00064	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—INS—Parkinson's disease	0.000401	0.000613	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPA8—Parkinson's disease	0.000395	0.000603	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CTGF—Parkinson's disease	0.000393	0.0006	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPA1A—Parkinson's disease	0.000359	0.000549	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCB1—Parkinson's disease	0.000349	0.0608	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—CASP3—Parkinson's disease	0.000299	0.000456	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—Parkinson's disease	0.000297	0.000453	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK8—Parkinson's disease	0.000274	0.000419	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—Parkinson's disease	0.000175	0.000268	CbGpPWpGaD
